Combined Multimorbidity and Polypharmacy Patterns in the Elderly: A Cross-Sectional Study in Primary Health Care

dc.contributor.authorStafford, Grant
dc.contributor.authorVillén, Noemí
dc.contributor.authorRoso Llorach, Albert
dc.contributor.authorTroncoso Mariño, Amelia
dc.contributor.authorMonteagudo, Mònica
dc.contributor.authorViolán, Concepción
dc.date.accessioned2021-09-27T13:02:39Z
dc.date.available2021-09-27T13:02:39Z
dc.date.issued2021-09-01
dc.date.updated2021-09-23T09:04:53Z
dc.description.abstract1) Background: The acquisition of multiple chronic diseases, known as multimorbidity, is common in the elderly population, and it is often treated with the simultaneous consumption of several prescription drugs, known as polypharmacy. These two concepts are inherently related and cause an undue burden on the individual. The aim of this study was to identify combined multimorbidity and polypharmacy patterns for the elderly population in Catalonia. (2) Methods: A cross-sectional study using electronic health records from 2012 was conducted. A mapping process was performed linking chronic disease categories to the drug categories indicated for their treatment. A soft clustering technique was then carried out on the final mapped categories. (3) Results: 916,619 individuals were included, with 93.1% meeting the authors' criteria for multimorbidity and 49.9% for polypharmacy. A seven-cluster solution was identified: one non-specific (Cluster 1) and six specific, corresponding to diabetes (Cluster 2), neurological and musculoskeletal, female dominant (Clusters 3 and 4) and cardiovascular, cerebrovascular and renal diseases (Clusters 5 and 6), and multi-system diseases (Cluster 7). (4) Conclusions: This study utilized a mapping process combined with a soft clustering technique to determine combined patterns of multimorbidity and polypharmacy in the elderly population, identifying overrepresentation in six of the seven clusters with chronic disease and chronic disease-drug categories. These results could be applied to clinical practice guidelines in order to better attend to patient needs. This study can serve as the foundation for future longitudinal regarding relationships between multimorbidity and polypharmacy.
dc.format.extent22 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn1660-4601
dc.identifier.pmid34501805
dc.identifier.urihttps://hdl.handle.net/2445/180292
dc.language.isoeng
dc.publisherMDPI AG
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/ijerph18179216
dc.relation.ispartofInternational Journal of Environmental Research and Public Health, 2021, vol. 18, num. 17, p. 9216
dc.relation.urihttps://doi.org/10.3390/ijerph18179216
dc.rightscc by (c) Stafford, Grant et al, 2021
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationPersones grans
dc.subject.classificationMorbiditat
dc.subject.classificationAprenentatge automàtic
dc.subject.otherOlder people
dc.subject.otherDiseases
dc.subject.otherMachine learning
dc.titleCombined Multimorbidity and Polypharmacy Patterns in the Elderly: A Cross-Sectional Study in Primary Health Care
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
ijerph-18-09216.pdf
Mida:
1.1 MB
Format:
Adobe Portable Document Format